Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Kenvue shares surge
Starboard Takes Stake in Consumer Products Maker Kenvue, Sources Say
(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, Listerine, and Tylenol, and which went public last year, two people familiar with the matter said on Sunday. Reuters was not able to immediately learn the size of the stake.
Kenvue shares surge after activist Starboard takes stake
Starboard Value has amassed a significant stake in Kenvue, which spun out of Johnson & Johnson in mid-2023, according to people familiar with the matter. Starboard's Jeff Smith is expected to detail the position further at 13D Monitor’s Active-Passive Investor Summit on Tuesday.
Kenvue's Double Catalysts: Starboard Stake and Dividend Announcement
Kenvue has a formidable lineup of well-known consumer health brands, such as Aveeno, Tylenol, Band-Aid, Zirtec, Listerine, and Neutrogena. These strong brand images can leverage the firm's growth and transformation of Kenvue.
18h
on MSN
Starboard says Kenvue's skin health segment weighing on performance
Hedge fund Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's ...
10h
Starboard Focused on Kenvue's Struggling Unit
Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
19h
10 Analysts Have This To Say About Kenvue
In the assessment of 12-month price targets, analysts unveil insights for Kenvue, presenting an average target of $24.1, a ...
FiercePharma
1d
Activist investor Starboard sets its sights on J&J spinout Kenvue: WSJ
Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has ...
23h
Kenvue price target raised to $27 from $24 at BofA
BofA raised the firm’s price target on Kenvue (KVUE) to $27 from $24 and keeps a Buy rating on the shares. Noting that The Wall Street ...
Yahoo Finance
1d
Kenvue stock jumps on reports of Starboard Value's stake
Kenvue
spun off from
Johnson
&
Johnson
(JNJ) in 2023. To watch more expert insights and analysis on the latest market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback